Anne Samuel
Stock Analyst at JP Morgan
(3.32)
# 992
Out of 4,876 analysts
66
Total ratings
54.76%
Success rate
1.95%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Maintains: Neutral | $63 → $60 | $61.09 | -1.78% | 6 | May 27, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $232 → $177 | $157.47 | +12.40% | 7 | May 19, 2025 | |
| OMCL Omnicell | Maintains: Neutral | $44 → $36 | $29.38 | +22.53% | 5 | Mar 20, 2025 | |
| VEEV Veeva Systems | Maintains: Neutral | $218 → $249 | $283.41 | -12.14% | 6 | Mar 20, 2025 | |
| EVH Evolent Health | Maintains: Overweight | $13 → $12 | $11.16 | +7.53% | 12 | Mar 10, 2025 | |
| PGNY Progyny | Maintains: Neutral | $17 → $23 | $21.91 | +4.97% | 7 | Jan 28, 2025 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $28.49 | -1.72% | 2 | Sep 9, 2024 | |
| PINC Premier | Maintains: Neutral | $21 → $19 | $21.61 | -12.08% | 4 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $22.96 | -8.54% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $3.81 | +241.21% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $39.76 | -32.09% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $3.81 | +31.23% | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $86 → $108 | $104.88 | +2.97% | 8 | Apr 2, 2024 |
Doximity
May 27, 2025
Maintains: Neutral
Price Target: $63 → $60
Current: $61.09
Upside: -1.78%
IQVIA Holdings
May 19, 2025
Maintains: Overweight
Price Target: $232 → $177
Current: $157.47
Upside: +12.40%
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44 → $36
Current: $29.38
Upside: +22.53%
Veeva Systems
Mar 20, 2025
Maintains: Neutral
Price Target: $218 → $249
Current: $283.41
Upside: -12.14%
Evolent Health
Mar 10, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $11.16
Upside: +7.53%
Progyny
Jan 28, 2025
Maintains: Neutral
Price Target: $17 → $23
Current: $21.91
Upside: +4.97%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $28.49
Upside: -1.72%
Premier
Sep 9, 2024
Maintains: Neutral
Price Target: $21 → $19
Current: $21.61
Upside: -12.08%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $22.96
Upside: -8.54%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $3.81
Upside: +241.21%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $39.76
Upside: -32.09%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $3.81
Upside: +31.23%
Apr 2, 2024
Maintains: Overweight
Price Target: $86 → $108
Current: $104.88
Upside: +2.97%